Genomic organisation of the mouse Ret proto-oncogene

被引:4
|
作者
Panetta, D
Yin, L
Barale, R
Romeo, G
Ravazzolo, R
Ceccherini, I
Puliti, A
机构
[1] Univ Pisa, Dept Sci Uomo & Ambiente, I-56126 Pisa, Italy
[2] Ist Giannina Gaslini, Genet Mol Lab, I-16148 Genoa, Italy
[3] Int Agcy Res Canc, F-69372 Lyon, France
[4] Univ Genoa, Dipartimento Oncol Biol & Genet, Genoa, Italy
来源
DNA SEQUENCE | 2001年 / 11卷 / 06期
关键词
Ret proto-oncogene; genomic structure; human/mouse sequence comparison; HSCR; MEN2;
D O I
10.3109/10425170109041333
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The RET proto-oncogene is involved in the development of both kidney and neural crests derived tissues. RET deleterious mutations cause hereditary neuroendocrine tumours and congenital intestinal aganglionosis. Ongoing efforts aimed at elucidating the function of this gene include expression studies in different species and in transgenic mice. As first step in the study of Rct expression in mouse, we obtained the mouse Ret genomic structure. Intron-exon boundaries were determined and sequenced, all introns, but the first one were amplified and cloned, and exons positioned in a restriction map. Mouse and human genes comparison indicates a highly conserved genomic organisation, except for exon 21 which is not conserved in mouse. A region extending 386 bp 5 ' to the first exon was sequenced and compared with its human counterpart. Some features, reported for the human promoter, like the absence of TATA or CAAT boxes and a high GC content, are conserved.
引用
收藏
页码:501 / 506
页数:6
相关论文
共 50 条
  • [1] cDNA sequence and genomic structure of the rat RET proto-oncogene
    Matera, I
    Miguel-Rodríguez, MD
    Fernández-Santos, JM
    Santamaria, G
    Puliti, A
    Ravazzolo, R
    Romeo, G
    Galera-Davidson, H
    Ceccherini, I
    DNA SEQUENCE, 2000, 11 (05): : 405 - 417
  • [2] RET proto-oncogene and thyroid cancer
    Komminoth, P
    ENDOCRINE PATHOLOGY, 1997, 8 (03) : 235 - 239
  • [3] RET proto-oncogene and thyroid cancer
    Paul Komminoth
    Endocrine Pathology, 1997, 8 : 235 - 239
  • [4] The RET proto-oncogene in sporadic pheochromocytomas
    Takaya, K
    Yoshimasa, T
    Arai, H
    Tamura, N
    Miyamoto, Y
    Itoh, H
    Nakao, K
    INTERNAL MEDICINE, 1996, 35 (06) : 449 - 452
  • [5] The RET proto-oncogene in human cancers
    Jhiang, SM
    ONCOGENE, 2000, 19 (49) : 5590 - 5597
  • [6] The RET proto-oncogene in human cancers
    Sissy M Jhiang
    Oncogene, 2000, 19 : 5590 - 5597
  • [7] Three novel mutations in the RET proto-oncogene
    Kalinin, VN
    Amosenko, FA
    Shabanov, MA
    Lubchenko, LN
    Hosch, SB
    Garkavtseva, RF
    Izbicki, JR
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2001, 79 (10): : 609 - 612
  • [8] Perspective on RET proto-oncogene and thyroid cancer
    Le, HN
    Norton, JA
    CANCER JOURNAL, 2000, 6 (02): : 50 - 57
  • [9] Expression of the RET proto-oncogene in human embryos
    Attié-Bitach, T
    Abitbol, M
    Gérard, M
    Delezoide, AL
    Augé, J
    Pelet, A
    Amiel, J
    Pachnis, V
    Munnich, A
    Lyonnet, S
    Vekemans, M
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1998, 80 (05): : 481 - 486
  • [10] Three novel mutations in the RET proto-oncogene
    V. Kalinin
    F. Amosenko
    M. Shabanov
    L. Lubchenko
    S. Hosch
    R. Garkavtseva
    J. Izbicki
    Journal of Molecular Medicine, 2001, 79 : 609 - 612